Hydrogen sulfide suppresses oxidized low-density lipoprotein (Ox-LDL)-stimulated monocyte chemoattractant protein 1 generation from macrophages via the nuclear factor κb (NF-κB) pathway

Journal of Biological Chemistry

Volumn 289, Issue 14, 2014, Pages 9741-9753

  Du, Junbao ^a   Huang, Yaqian ^a   Yan, Hui ^a   Zhang, Qiaoli ^a   Zhao, Manman ^a   Zhu, Mingzhu ^a   Liu, Jia ^a   Chen, Stella X ^b   Bu, Dingfang ^a   Tang, Chaoshu ^c,d   Jin, Hongfang ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^d PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; BODY FLUIDS; HYDROGEN SULFIDE; LIPOPROTEINS; NUCLEIC ACIDS; PATHOLOGY; PHOSPHORYLATION; SULFUR DETERMINATION;

DNA BINDING ACTIVITY; FREE THIOL GROUP; INHIBITING EFFECT; MOLECULAR MECHANISM; NUCLEAR TRANSLOCATIONS; OXIDIZED LOW-DENSITY LIPOPROTEINS; POSSIBLE MECHANISMS; SODIUM HYDROSULFIDE;

MACROPHAGES;

ACRYLIC ACID; ACRYLIC ACID HEXYL ESTER; CYSTATHIONINE BETA SYNTHASE; CYSTEINE; DITHIOTHREITOL; HYDROGEN SULFIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INORGANIC COMPOUND; MONOCYTE CHEMOTACTIC PROTEIN 1; OXIDIZED LOW DENSITY LIPOPROTEIN; SERINE; SODIUM HYDROSULFIDE; THIOL GROUP; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CHEMICAL REACTION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; INFLAMMATION; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; SULFHYDRATION;

HYDROGEN SULFIDE; INFLAMMATION; MACROPHAGES; NF-ΚB; SULFHYDRYL;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; CELL LINE; CELL NUCLEUS; CHEMOKINE CCL2; GASOTRANSMITTERS; GENE EXPRESSION REGULATION; HUMANS; HYDROGEN SULFIDE; INFLAMMATION; LIPOPROTEINS, LDL; MACROPHAGES; MICE; PHOSPHORYLATION; RNA, MESSENGER; TRANSCRIPTION FACTOR RELA;

EID: 84898062814     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.517995     Document Type: Article

References (50)

1. Ross, R. (1999) Atherosclerosis. An inflammatory disease. N. Engl. J. Med. 340, 115-126
2. Hansson, G. K., Libby, P., Schönbeck, U., and Yan, Z. Q. (2002) Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ. Res. 91, 281-291
3. Gong, J. H., Ratkay, L. G., Waterfield, J. D., and Clark-Lewis, I. (1997) An antagonist of monocyte chemoattractant protein 1 (MCP-1) inhibits arthritis in the MRL-lpr mouse model. J. Exp. Med. 186, 131-137
4. Yoshimura, T., Robinson, E. A., Tanaka, S., Appella, E., and Leonard, E. J. (1989) Purification and amino acid analysis of two human monocyte che-moattractants produced by phytohemagglutinin-stimulated human blood mononuclear leukocytes. J. Immunol. 142, 1956-1962
5. Yoshimura, T., Yuhki, N., Moore, S. K., Appella, E., Lerman, M. I., and Leonard, E. J. (1989) Human monocyte chemoattractant protein-1 (MCP-1). Full-length cDNA cloning, expression in mitogen-stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE. FEBS Lett. 244, 487-493
6. 2S be the third endogenous gaseous transmitter? FASEB J. 16, 1792-1798
7. Shibuya, N., Koike, S., Tanaka, M., Ishigami-Yuasa, M., Kimura, Y., Ogasawara, Y., Fukui, K., Nagahara, N, and Kimura, H. (2013) A novel pathway for the production of hydrogen sulfide from D-cysteine in mammalian cells. Nat Commun. 4, 1366
8. Shibuya, N, and Kimura, H. (2013) Production of hydrogen sulfide from D-cysteine and its therapeutic potential. Front. Endocrinol. 4, 87
9. Kimura, H. (2014) Production and physiological effects of hydrogen sulfide. Antioxid. Redox Signal. 20, 783-793
10. Tang, C, Li, X., Du, J. (2006) Hydrogen sulfide as a new endogenous gaseous transmitter in the cardiovascular system. Curr. Vasc. Pharmacol. 4, 17-22
11. Du, J., Zhang, C, Yan, H., and Tang, C. (2006) A newly found gasotrans-mitter, hydrogen sulfide, in the pathogenesis of hypertension and other cardiovascular diseases. Curr. Hypertens. Rev. 2, 123-126
12. Lefer, D. J. (2007) A new gaseous signaling molecule emerges. Cardioprotective role of hydrogen sulfide. Proc. Natl. Acad. Sci. U.S.A. 104, 17907-17908
13. Whiteman, M., Li, L., Rose, P., Tan, C. H., Parkinson, D. B., and Moore, P. K. (2010) The effect of hydrogen sulfide donors on lipopolysaccharide-induced formation of inflammatory mediators in macrophages. Antioxid. Redox. Signal. 12, 1147-1154
14. Li, T., Zhao, B., Wang, C, Wang, H., Liu, Z., Li, W., Jin, H., Tang, C, and Du, J. (2008) Regulatory effects of hydrogen sulfide on IL-6, IL-8 andIL-10 levels in the plasma and pulmonary tissue of rats with acute lung injury. Exp. Biol. Med. 233, 1081-1087
15. Li, L., Salto-Tellez, M., Tan, C. H., Whiteman, M., and Moore, P. K. (2009) GYY4137, a novel hydrogen sulfide-releasing molecule, protects against endotoxic shock in the rat. Free. Radic. Biol. Med. 47, 103-113
16. Wang, Y., Zhao, X., Jin, H., Wei, H., Li, W., Bu, D., Tang, X., Ren, Y., Tang, C., and Du, J. (2009) Role of hydrogen sulfide in the development of atherosclerotic lesions in apolipoprotein E knockout mice. Arterioscler. Thromb. Vasc. Biol. 29, 173-179
17. Auwerx, J. (1991) The human leukemia cell line, THP-1. A multifaceted model for the study of monocyte-macrophage differentiation. Experientia 47, 22-31
18. Cushing, S. D., Berliner, J. A., Valente, A. J., Territo, M. C, Navab, M., Parhami, F., Gerrity, R., Schwartz, C. J., and Fogelman, A. M. (1990) Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc. Natl. Acad. Sci. U.S.A. 87, 5134-5138
19. Li, W., Tang, C, Jin, H., Du, J. (2011) Regulatory effects of sulfur dioxide on the development of atherosclerotic lesions and vascular hydrogen sulfide in atherosclerotic rats. Atherosclerosis 215, 323-330
20. Olson, K. R. (2009) Is hydrogen sulfide a circulating "gasotransmitter" in vertebrate blood? Biochim. Biophys. Acta 1787, 856-863
21. Chen, B., Li, W., Lv, C, Zhao, M., Jin, H., Jin, H., Du, J., Zhang, L., and Tang, X. (2013) Fluorescent probe for highly selective and sensitive detection of hydrogen sulfide in living cells and cardiac tissues. Analyst 138, 946-951
22. 2S signals through protein S-sulfhydration. Sci. Signal. 2, ra72
23. Baskar, R., and Bian, J. (2011) Hydrogen sulfide gas has cell growth regulatory role. Eur. J. Pharmacol. 656, 5-9
24. Liu, Y. H, Lu, M., Hu, L. F., Wong, P. T., Webb, G. D., Bian, J. S. (2012) Hydrogen sulfide in the mammalian cardiovascular system. Antioxid. Redox Signal. 17, 141-185
25. Zhao, Z. Z., Wang, Z., Li, G. H., Wang, R., Tan, J. M., Cao, X., Suo, R., and Jiang, Z. S. (2011) Hydrogen sulfide inhibits macrophage-derivedfoam cell formation.Exp. Biol. Med. 236, 169-176
26. /~ mice. Br. J. Pharmacol. 169, 1795-1809
27. Standiford, T. J., Kunkel, S. L., Phan, S. H., Rollins, B. J., and Strieter, R. M. (1991) Alveolar macrophage-derived cytokines induce monocyte che-moattractant protein-1 expression from human pulmonary type II-like epithelial cells. J. Biol. Chem. 266, 9912-9918
28. Brown, Z., Strieter, R. M., Neild, G. H, Thompson, R. C, Kunkel, S. L., and Westwick, J. (1992) IL-1 receptor antagonist inhibits monocyte chemotactic peptide 1 generation by human mesangial cells. Kidney Int. 42, 95-101
29. Barna, B. P., Pettay, J., Barnett, G. H., Zhou, P., Iwasaki, K., and Estes, M. L. (1994) Regulation of monocyte chemoattractant protein-1 expression in adult human non-neoplastic astrocytes is sensitive to tumor necrosis factor (TNF) or antibody to the 55-kDa TNF receptor. JNeuroimmunol. 50, 101-107
30. Fruebis, J., Gonzalez, V., Silvestre, M., and Palinski, W. (1997) Effect of probucol treatment on gene expression of VCAM-1, MCP-1, and M-CSF in the aortic wall of LDL receptor-deficient rabbits during early athero-genesis. Arterioscler. Thromb. Vasc. Biol. 17, 1289-1302
31. Shioi, A., Katagi, M., Okuno, Y., Mori, K., Jono, S., Koyama, H, and Nishizawa, Y. (2002) Induction of bone-type alkaline phosphatase in human vascular smooth muscle cells. Roles of tumor necrosis factor-a and oncostatin M derived from macrophages. Circ. Res. 91, 9-16
32. Ueda, A., Okuda, K., Ohno, S., Shirai, A., Igarashi, T., Matsunaga, K., Fukushima, J., Kawamoto, S., Ishigatsubo, Y., and Okubo, T. (1994) NF-KB and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene. J. Immunol. 153, 2052-2063
33. Freter, R. R., Alberta, J. A., Hwang, G. Y., Wrentmore, A. L., and Stiles, C. D. (1996) Platelet-derived growth factor induction of the immediate-early gene MCP-1 is mediated by NF-KB and a 90-kDa phosphoprotein coactivator. J. Biol. Chem. 271, 17417-17424
34. Martin, T., Cardarelli, P. M., Parry, G. C, Felts, K. A., and Cobb, R. R. (1997) Cytokine induction of monocyte chemoattractant protein-1 gene expression in human endothelial cells depends on the cooperative action of NF-KB and AP-1. Eur. J. Immunol. 27, 1091-1097
35. Marumo, T., Schini-Kerth, V. B., and Busse, R. (1999) Vascular endothelial growth factor activates nuclear factor- and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells. Diabetes 48, 1131-1137
36. Ha, H, Yu, M. R., Choi, Y. J., Kitamura, M., and Lee, H. B. (2002) Role of high glucose-induced nuclear factor- activation in monocyte chemoattractant protein-1 expression by mesangial cells. J. Am. Soc. Nephrol. 13, 894-902
37. Baeuerle, P. A., and Henkel, T. (1994) Function and activation of NF-KB in the immune system. Annu. Rev. Immunol. 12, 141-179
38. Huang, T. T., andMiyamoto, S. (2001) Postrepression activation of NF-KB requires the amino-terminal nuclear export signal specific to IKBC*. Mol. Cell Biol. 21, 4737-4747
39. Sen, N, Paul, B. D., Gadalla, M. M., Mustafa, A. K., Sen, T., Xu, R., Kim, S., and Snyder, S. H. (2012) Hydrogen sulfide-linked sulfhydration of NF-KB mediates its antiapoptotic actions. Mol. Cell. 45, 13-24
40. Li, L., Rose, P., and Moore, P. K. (2011) Hydrogen sulfide and cell signaling. Annu. Rev. Pharmacol. Toxicol. 51, 169-187
41. Smith, R. P., andAbbanat, R. A. (1966) Protective effect of oxidized glutathione in acute sulfide poisoning. Toxicol. Appl. Pharmacol. 9, 209-217
42. Zhang, R., Sun, Y., Tsai, H, Tang, C, Jin, H., and Du, J. (2012) Hydrogen sulfide inhibits L-type calcium currents depending upon the protein sulf-hydryl state in rat cardiomyocytes. PloS ONE 7, e37073
43. Sandur, S. K., Ichikawa, H., Sethi, G., Ahn, K. S., and Aggarwal, B. B. (2006) Plumbagin (5-hydroxy-2-methyl-1, 4-naphthoquinone) suppresses NF-KB activation and NF-KB-regulated gene products through modulation of p65 and IKBC* kinase activation, leading to potentiation of apoptosis induced by cytokine and chemotherapeutic agents. J. Biol. Chem. 281, 17023-17033
44. Han, Y., Englert, J. A., Yang, R., Delude, R. L., and Fink, M. P. (2005) Ethyl pyruvate inhibits nuclear factor-KB-dependent signaling by directly targeting p65. J. Pharmacol. Exp. Ther. 312, 1097-1105
45. Yadav, V. R., Prasad, S., Gupta, S. C, Sung, B., Phatak, S. S., Zhang, S., and Aggarwal, B. B. (2012) 3-Formylchromone interacts with cysteine 38 in p65 protein and with cysteine 179 in IKBC* kinase, leading to down-regulation of nuclear factor-KB (NF-KB)-regulated gene products and sensitization of tumor cells. J. Biol. Chem. 287, 245-256
46. García-Piñeres, A. J., Castro, V., Mora, G., Schmidt, T. J., Strunck, E., Pahl, H. L., and Merfort, I. (2001) Cysteine 38 in p65/NF-KB plays a crucial role in DNA binding inhibition by sesquiterpene lactones. J. Biol. Chem. 276, 39713-39720
47. García-Piñeres, A. J., Lindenmeyer, M. T., and Merfort, I. (2004) Role of cysteine residues of p65/NF- on the inhibition by the sesquiterpene lactone parthenolide and N-ethyl maleimide, and on its transactivating potential. Life Sci. 75, 841-856
48. Chen, F. E., Huang, D. B., Chen, Y. Q., and Ghosh, G. (1998) Crystal structure of p50/p65 heterodimer of transcription factor NF-KB bound to DNA. Nature 391, 410-413
49. Kelleher, Z. T., Matsumoto, A., Stamler, J. S., and Marshall, H. E. (2007) NOS2 regulation of NF-KB by S-nitrosylation of p65. J. Biol. Chem. 282, 30667-30672
50. Namekata, K., Enokido, Y., Ishii, I., Nagai, Y., Harada, T., and Kimura, H. (2004) Abnormal lipid metabolism in cystathionine/3-synthase-deficient mice, an animal model for hyperhomocysteinemia. J. Biol. Chem. 279, 52961-52969